Iatrogenic matrix calculi.
D000328:Adult; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects; D005122:Exudates and Transudates; D005260:Female; D006801:Humans; D007036:Hypothermia, Induced; D007049:Iatrogenic Disease; D007669:Kidney Calculi / Q000139:chemically induced / Q000188:drug therapy / Q000601:surgery*; D008297:Male; D011512:Proteus Infections / Q000150:complications / Q000188:drug therapy; D011704:Pyelonephritis / Q000209:etiology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013444:Sulfisoxazole / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014527:Uric Acid; D014552:Urinary Tract Infections / Q000150:complications; D014567:Urography
D000892:Anti-Infective Agents, Urinary; D013449:Sulfonamides; D014527:Uric Acid; D013444:Sulfisoxazole; D013752:Tetracycline